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Abstract
Niemann-Pick Type C (NPC) disease is a lysosomal storage disorder characterized by accumulation of unesterified
cholesterol and other lipids in the endolysosomal system. NPC disease results from a defect in either of two distinct
cholesterol-binding proteins: a transmembrane protein, NPC1, and a small soluble protein, NPC2. NPC1 and NPC2 are
thought to function closely in the export of lysosomal cholesterol with both proteins binding cholesterol in vitro but they
may have unrelated lysosomal roles. To investigate this possibility, we compared biochemical consequences of the loss of
either protein. Analyses of lysosome-enriched subcellular fractions from brain and liver revealed similar decreases in
buoyant densities of lysosomes from NPC1 or NPC2 deficient mice compared to controls. The subcellular distribution of
both proteins was similar and paralleled a lysosomal marker. In liver, absence of either NPC1 or NPC2 resulted in similar
alterations in the carbohydrate processing of the lysosomal protease, tripeptidyl peptidase I. These results highlight
biochemical alterations in the lysosomal system of the NPC-mutant mice that appear secondary to lipid storage. In addition,
the similarity in biochemical phenotypes resulting from either NPC1 or NPC2 deficiency supports models in which the
function of these two proteins within lysosomes are linked closely.
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Introduction
Niemann Pick Type C (NPC) disease is a neurovisceral
lysosomal storage disease that results from mutations in either of
two distinct genes: NPC1 (accounting for ,95% of cases) or NPC2
(,5% of cases). Diseases arising from mutations in either gene are
clinically indistinguishable and are characterized by an accumu-
lation of cholesterol and other lipids within the lysosomes of
affected individuals (reviewed in [1,2]). NPC1 encodes the
endolysosomal membrane protein NPC1, a 1278 amino acid
glycoprotein with 13 transmembrane segments and a sterol-
sensing domain [3] that binds sterols including cholesterol [4,5,6].
NPC2 encodes a 132 amino-acid soluble glycoprotein, NPC2, that
primarily localizes to lysosomes [7,8] and which also binds
cholesterol and other sterols [9,10,11,12].
The precise interactions between NPC1 and NPC2 that are
required for the lysosomal export of cholesterol have been the
focus of considerable attention. Genetic studies have demonstrat-
ed that the loss of NPC1, NPC2 or both proteins in mice results
in essentially identical phenotypes, suggesting that NPC1 and
NPC2 function in concert [13]. In addition, recent biochemical
studies indicate that NPC2 can facilitate the intermembrane
transfer of cholesterol [14,15] and can transfer it to NPC1
[16,17,18]. The lipid environment can affect NPC2-mediated
lipid transfer, with lysosomal phospholipid lyso-bisphosphatidic
acid and ceramide accelerating transfer [15,19] and sphingomy-
elin inhibiting transfer [19] (reviewed in [20,21]). Together, these
observations provide a basis for a model in which NPC2
transports cholesterol from inner lysosomal membrane structures
or microaggregates directly to a sterol binding site in the N-
terminal domain of NPC1, which in turn is required for its
subsequent egress from the lysosome [1,22]. This model would
appear to require NPC1 and NPC2 to colocalize to some extent.
NPC2 clearly resides within the lysosome [7]. The subcellular
location of NPC1 is less clear but it is generally thought to reside
within the late endosome [23] and the lysosome [24] (reviewed in
[25]).
In addition to their intricately-linked roles in cholesterol
transport, it is possible that NPC1 and NPC2 may also have other,
unrelated functions within the lysosome [26]. In this study, we have
investigated this possibility by comparing the biochemical conse-
quences of the loss of each protein in the respective mutant mice.
The rationale underlying this approach is that if the NPC1 and
NPC2 have different functions within the lysosome then in the
absence of either protein, there may be differences in the
biochemical phenotype.
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Survival of BALB/c NPC mutants
While the spontaneous Npc1 mutant mouse appears to be a null
[27], gene targeting of Npc2 resulted in a mouse that expresses up
to 4% of normal levels of functional NPC2 protein [13], thus the
Npc2 mouse model is technically a hypomorph. Previous
comparison of survival of mutant mice indicated that the
phenotype of the Npc2 mutant was extremely similar but
attenuated compared to the Npc1 or Npc1/Npc2 double mutants
[13]. This attenuation likely reflected residual NPC2 expression
thus epistasis arguments suggested that both proteins functioned in
a common pathway. However, interpretation of these results was
complicated by the fact that these studies were conducted using
mutants with an indeterminate (mixed C57BL/6, 129SvEv and
BALB/c) genetic background and that strain background could
have a significant effect on survival. To exclude possible strain
effects, we introduced the Npc2 mutant allele into a BALB/c
background by backcrossing and compared the phenotype of these
congenic animals with the Npc1 mutant in the same strain (Fig.1).
We find that mice lacking NPC1 have the shortest life span with
median survival 73 days (95% confidence interval (c.i.), 69 to 75
days). Survival of NPC2-deficient mice was significantly longer
than that of Npc1 single mutants (log rank test p,0.0001), with
median survival 110 days (95% c.i. 106 to 116 days). Survival of
mutant mice with deficiencies in both NPC1 and NPC2 was
similar to those lacking NPC1 alone, with median survival 83 days
(95% c.i. 72 to .83 days). These data verify that the phenotype of
the Npc2 mutant is attenuated compared to the Npc1 mutant and
eliminates the possibility that the difference in survival could be
related to strain effects.
Effect of the loss of NPC1 and NPC2 on biophysical
properties of liver and brain organelles
NPC disease is associated with a block in the intracellular
trafficking of unesterified cholesterol and other lipids, leading to
their accumulation within the endosomal/lysosomal system. If
both NPC1 and NPC2 proteins function in a common pathway,
deficiencies in either should produce similar effects on the
biophysical properties of lysosomes. Previously, we conducted
subcellular fractionation of brains from symptomatic Npc2 mutants
and found significant decrease in the buoyant density of the
lysosome but not in other cellular organelles [28]. Others have
found a decrease in the buoyant density of lysosomes in the liver,
spleen and lung from symptomatic Npc1-mutant animals [29,30].
Given the complex pathological cascades that are associated with
disease progression, we used presymptomatic animals to investi-
gate the effect of NPC1 and NPC2 deficiencies on the properties of
brain and liver organelles.
Lysosomal enzyme activities b-galactosidase and tripeptidyl
peptidase I (TPP1) , as well as markers from other organelles
including mitochondria (cytochrome c oxidase), endoplasmic
reticulum (a-glucosidase II), peroxisomes (catalase) and plasma
membrane (alkaline phosphodiesterase) were measured in
differential centrifugation fractions isolated using the classical
five fraction scheme [31]. Fractions are nuclear (N), heavy
mitochondrial (M), light mitochondrial (L), microsomal (P) and
high-speed supernatant (S). In wild-type liver, as expected, the
highest specific activity for each lysosomal enzyme was found in
the L fraction with the majority of the activity being in the M
fraction (Fig. 2). (Note in this presentation, for each fraction, the
height of the bar represents the enrichment of the specific activity
(activity/protein) of interest compared to the initial homogenate
while the area of the bar represents the proportion of total activity
found in that fraction). Relative distributions of the lysosomal
markers in the differential centrifugation fractions from livers of
the NPC-mutant mice were similar to those of wild-type mice but
there were some differences. There was a consistent decrease in
the enrichment of the lysosomal markers in the L fraction of
NPC-mutant livers with a concomitant increase in the S fraction
(based on 4 independent experiments). The pathogenic implica-
tions of these observations are difficult to evaluate as the
appearance of luminal lysosomal hydrolases in the S fraction
most likely occurs due to rupture of large, lipid-laden lysosomes
that occurs when homogenizing NPC-deficient liver [30].
Relative distributions of the markers for other organelles were
similar in the differential centrifugation fractions from NPC-
mutant livers (Fig. 2). In the brain, the absence of either NPC1 or
NPC2 had no significant effect on the relative distribution of the
lysosomal markers (Fig. 3), as noted previously for NPC2 [28].
This differs from other reports [32] but may reflect the fact that
we analyze the complete brain, rather than discrete regions.
Alternatively, this may be due to differences in preparing the
organelle-enriched subcellular fractions.
We performed sucrose density gradient centrifugation on a
combined ML differential centrifugation fraction prepared from
the liver (Fig. 4) and the brain (Fig. 5) and determined
distributions of lysosomes and other cellular organelles by
measuring the marker enzymes. In both the liver and the brain,
distributions of the lysosomal markers revealed a dramatic shift in
the buoyant density of lysosomes prepared from the mutants
compared to those of control wild-type mice (Figs. 4 and 5). In
the liver, both Npc1 and Npc2 mutants exhibited a change in the
appearance of alkaline phosphodiesterase, compared to wild-type
animals, with some of the activity shifting to a lower density.
While this enzyme is typically regarded as a plasma membrane
marker, others have reported some localization within the
lysosome [33]. In contrast, analysis of other marker activities
indicated that the density of liver and brain mitochondria and
endoplasmic reticulum, brain plasma membrane, and liver
peroxisomes did not appear to be affected by the loss of either
NPC protein (Figs. 4 and 5). Most importantly, while both Npc1
and Npc2 mutants exhibited marked differences compared to
controls, there were no appreciable differences in the organelle
properties of both mutants.
Figure 1. Survival of the NPC-mutant mice. Wild-type (solid line,
n=381 animals, 8 deaths), Npc1 mutants (#, n=134 animals, 91
deaths), Npc2 mutants (%, n=150 animals, 66 deaths) and Npc1/Npc2
double mutants (&, n=15 animals, 9 deaths) were in a BALB/c genetic
background.
doi:10.1371/journal.pone.0023677.g001
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mutant mice
We investigated the subcellular distribution of NPC1 and NPC2
proteins in the NPC-mutant mice by immunodetection in both the
differential centrifugation fractions and sucrose density gradients
of ML fractions prepared from liver (Fig. 6) and brain (Fig. 7). In
the differential centrifugation fractions, distribution of the
membrane-associated NPC1 was unaffected by the absence of
NPC2, and vice versa, in either the liver or the brain (Fig. 6, Panel
A and Fig. 7, Panel A). Immunoblotting indicated that the
distribution of the cation-independent mannose 6-phosphate
receptor (CI-MPR), which traffics between the trans-Golgi
network, plasma membrane, and early and late endosomes [34]
appeared unaltered by the absence of NPC1 or NPC2.
Distribution of NPC1 and NPC2 in the NPC-mutant mice was
also investigated by sucrose density gradient centrifugation (Fig. 6,
Panels B and C; Fig. 7, Panels B and C). In wild-type mice, both
NPC1 and NPC2 colocalized to high-density gradient fractions
(liver fractions 7–12 (Fig. 6), brain fractions 5–8 (Fig. 7)). However,
in the mutant mouse livers and brains, NPC1 and NPC2 were
distributed across the gradient with peaks at a low-density region
(liver fractions 1–5 (Fig. 6), brain fractions 2–5 (Fig.7)). These data
are consistent with NPC1 and NPC2 residing in a lysosomal
compartment that is similarly affected by the lipidosis induced by a
NPC1 or NPC2 deficiency. However, it is interesting to note that
in both wild-type brain and liver, the distribution of NPC1 appears
to be slightly shifted towards lower density fractions compared to
NPC2 and b-galactosidase, which essentially cofractionate (Fig. 8).
This may indicate a subtle difference in the subcellular localization
of NPC1 and NPC2. Alternatively, this may reflect intrinsic
differences in the density distribution of lysosomal membrane
proteins (e.g., NPC1) versus soluble proteins (e.g., NPC2) [35]. For
example, in a lysosomal population of heterogeneous size, the
specific activity (i.e., activity per unit protein) of membrane
proteins will decrease with increasing lysosome size, reflecting the
decreasing ratio between membrane surface area and volume of
the lumen (which contains the bulk of protein). In the absence of
lipidoses, as the membrane surface area to volume ratio decreases,
the density of the lysosome will increase as the relative proportion
of membrane lipids is decreased. In effect, this will increase the
relative specific activity of membrane proteins in the smaller, lower
density particles.
Glycosylation of lysosomal proteins in the NPC-mutant
mice
Most newly synthesized soluble lysosomal proteins are
glycoproteins that are transported to lysosomes by virtue of a
specific targeting signal, mannose-6-phosphate. The N-linked
glycans undergo considerable processing, both during transit
through the ER and Golgi as well as after delivery to lysosomes.
In the lysosome, sugars on these proteins, including NPC2, are
processed by other lysosomal enzymes e.g., a-mannosidase
[36,37,38] but are not completely removed. Mature lysosomal
proteins exhibit signature glycosylation patterns that can differ in
different cell types and tissues. When analyzed by SDS-PAGE,
murine liver NPC2 normally migrates as several bands that likely
result from heterogeneity in its single N-linked oligosaccharide
[39]. It has been reported that the glycosylation of NPC2, as
reflected by electrophoretic mobility, is altered in NPC1-deficient
mouse liver compared to wild-type controls, with a shift towards a
higher molecular weight glycosylated form. This alteration in
carbohydrate processing was suggested to be specific to NPC2
rather than reflecting a widespread cellular defect. This led to the
proposal that deficiencies in NPC1 resulted in a malfunction of
NPC2 as reflected by aberrant glycosylation [39], and that this
was the basis for the cholesterol storage observed in NPC1
disease.
We also find that the appearance of NPC2 is different in wild-
type and NPC1-deficient liver. Fig. 6, Panel D shows magnified
immunoblots of NPC2 detected in the L differential centrifugation
fractions from wild-type and Npc1-mutant mice. (Given that NPC2
is expressed more abundantly in the Npc1-mutant mice, the two
panels have been grey-scale matched to allow qualitative
comparison of the NPC2 isoforms). In the wild-type mouse,
NPC2 is detected as a doublet of apparent Mr of 18 and 20 kDa
but in the Npc1-mutant, it is detected only as the higher weight
isoform. Treatment of liver extracts from both wild-type and Npc1-
mutant mice with PNGase F to remove N-linked oligosaccharides
resulted in a collapse of all NPC2 isoforms to an identical, lower
molecular weight species, indicating that the changes in the mass
of NPC2 in the absence of NPC1 arise from differences in N-
linked glycosylation (Fig. 9). These findings are consistent with
previous observations from liver [39]. However, in brain, we find
no apparent changes in the glycosylation of NPC2 in the absence
of NPC1 (Fig. 7). Given that neurodegeneration is a prominent
feature of NPC disease, these results do not appear to be consistent
with aberrant glycosylation of NPC2 being associated with disease.
To investigate the specificity of these changes in glycosylation,
we also examined TPP1, another soluble lysosomal protein, in
liver from both NPC1- and NPC2-deficient mice (Fig. 9). In wild-
type liver, TPP1 migrates on SDS-PAGE as a heterogeneous
series of bands of ,45–48 kDa. However, we find that in the
absence of either NPC1 or NPC2, TPP1 now migrates
predominantly as a single band that corresponds to the higher
mass isoforms detected in the wild-type liver. PNGase F
treatment shifts all the bands to a lower molecular weight species
(Fig. 9). These results indicate that alterations in glycosylation
observed in liver in the absence of NPC1 are not specific to the
NPC2 protein. Furthermore, alterations in the glycosylation of
TPP1 are observed in the absence of either NPC1 or NPC2.
Taken together, these results indicate that the alterations in the
glycosylation of soluble lysosomal proteins in liver are a
secondary effect of NPC disease resulting from either Npc1 or
Npc2 mutations. Thus, altered processing of NPC2 in the absence
of NPC1 is unlikely to be of pathogenic consequence. This
conclusion is supported by the earlier finding that all glycoforms
of NPC2 bound cholesterol and could ameliorate the cholesterol
storage phenotype of fibroblasts from NPC2 patients [10],
indicating that heterogeneity in glycosylation appears not to be
directly related to its function.
Figure 2. Relative distributions of marker enzymes in differential centrifugation fractions of livers of wild-type and NPC-mutant
mice. Subcellular fractions were generated from livers of wild-type and Npc1- and Npc2-mutant mice by differential centrifugation. Fractions were
analyzed for the following marker enzymes: b-galactosidase (lysosome), tripeptidyl peptidase I (lysosome), cytochrome c oxidase (mitochondria), a-
glucosidase II (endoplasmic reticulum), catalase (peroxisome) and alkaline phosphodiesterase (plasma membrane). Ordinate, relative specific activity
of each fraction (proportion of total recovered activity/proportion of total recovered protein). Abscissa, relative protein content of fraction
(cumulative from left to right). Areas are proportional to the total activity in any given fraction. Fractions are nuclear (N), heavy mitochondrial (M),
light mitochondrial (L), microsomal (P) and high-speed supernatant (S).
doi:10.1371/journal.pone.0023677.g002
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mice. Details are as in Figure 2. Note that catalase activity was very low in brain and is not shown.
doi:10.1371/journal.pone.0023677.g003
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Recent studies indicate that the loss of a-mannosidase activity
results in defective processing of N-linked oligosaccharides with
increased levels of glycosylation on NPC2 and other lysosomal
proteins [37,38]. We therefore considered the possibility that the
altered glycosylation of NPC2 and TPP1 in liver in the absence
of NPC1 might reflect a decrease in the activity of a-
mannosidase that is secondary to the primary defect in
cholesterol transport. We find that a-mannosidase activity is
increased in brain in the absence of either NPC1 or NPC2
(Fig. 10), and this is consistent with the normal carbohydrate
processing of lysosomal proteins in this organ (Fig. 7). In liver,
where deglycosylation of lysosomal proteins is impaired in the
absence of NPC1 or NPC2 (Fig. 9), a-mannosidase activity is
unaffected by the loss of either protein (Fig. 10). This indicates
that a down-regulation of a-mannosidase synthesis is not the
cause of impaired deglycosylation. However, the possibility that
the accumulation of storage lipids within the lysosome might
reduce a-mannosidase activity or limit accessibility to certain
substrates, cannot be excluded.
Concluding Remarks
The aim of this study was to use biochemical tests to determine
whether NPC1 and NPC2 might have unrelated functions within
Figure 4. Enzyme distribution in sucrose density gradient fractions from livers of wild-type and NPC-mutant mice. ML differential
centrifugation fractions were prepared from livers of wild-type (black solid line), Npc1 mutant (grey solid line) and Npc2 mutant (black dotted line)
mice and were then fractionated on sucrose density gradients. Relative enzyme activities (proportion in each fraction of total recovered activity) are
plotted against densities of the respective fractions.
doi:10.1371/journal.pone.0023677.g004
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rationale was that if these proteins function exclusively in
cholesterol transport, then the loss of either would be predicted
to yield similar phenotypes. Conversely, should NPC1 or NPC2
have a unique function within the lysosome, then we hoped to
observe specific differences in the biochemical phenotype in the
absence of either protein. We find that NPC1 and NPC2 appear to
have considerable overlap in distributions and that a deficiency in
either protein elicits similar shifts in the buoyant density of the
organelle. We also find that the loss of either NPC1 or NPC2 both
result in aberrant carbohydrate processing of another lysosomal
protein, TPP1. This indicates that the altered glycosylation of
NPC2 observed in the absence of NPC1 [39] is not specific to
NPC2 and thus altered glycosylation of NPC2 appears not to be
the primary cause of disease as has been suggested elsewhere [39].
These data, along with our previous measurements of storage
material and neuropathological analysis of Npc1 and Npc2 mutants
[13] are entirely consistent with roles for NPC1 and NPC2 in the
lysosome in sequential steps of a cellular cholesterol transport
pathway.
The model that NPC1 and NPC2 play closely related roles in
lysosomal cholesterol transport does not preclude additional
specialized extralysosomal roles for these two proteins. For
instance, NPC2 is secreted into epididymal fluid [40] and breast
milk [41] and could conceivably play a role in sterol transport in
such extracellular aqueous environments. NPC2 is also present in
Figure 5. Enzyme distribution in sucrose density gradient fractions from brains of wild-type and NPC-mutant mice. Details as in
Figure 4.
doi:10.1371/journal.pone.0023677.g005
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although its presence here appears not to be required for the
intestinal uptake of cholesterol [43]. If, like the RND permeases,
NPC1 plays a role in trans-bilayer transport of a variety of
hydrophobic and amphipathic molecules, it could be potentially be
involved in the lysosomal egress of a wider range of substrates than
is bound by NPC2. Interestingly, while NPC1 binds cholesterol
and oxysterols [4], NPC2 exhibits little or no affinity for the latter
[5,10]. Nonetheless, given that cholesterol is one of the major
lipids in all mammalian cells and it maintains a considerable flux
through the lysosome, it seems likely that the primary function of
both proteins lies in facilitating lysosomal cholesterol egress and




All experiments and procedures involving live animals were
conducted in compliance with protocols approved by the Robert
Wood Johnson Medical School Institutional Animal Care and Use
Committee (‘‘Animal Models to Investigate Niemann-Pick Type C
Disease’’, protocols I10-010 and I07-006). All efforts were made to
minimize suffering.
Primary antibodies
A rabbit polyclonal antibody raised against NPC1 was kindly
provided by Dr. Daniel S. Ory. Rabbit polyclonal antibodies
against NPC2 (affinity purified preparation HL5895), TPP1 (bleed
Figure 6. Distribution of NPC1 and NPC2 in subcellular fractions of livers of wild-type and NPC-mutant mice. A. Equivalent amounts of
protein of the indicated differential centrifugation fractions were fractionated by SDS-PAGE gels and NPC1, NPC2 and CI-MPR were detected by
western blotting. ML differential centrifugation fractions of livers from wild-type, Npc1- and Npc2-mutant mice were further fractionated on sucrose
density gradients. Volume equivalents of the gradient fractions were run on SDS-PAGE gels and were probed for NPC1 (B) and NPC2 (C)b y
immunoblotting. Note that a non-specific band is detected that migrates in approximately the same position as NPC1 (indicated by asterisk in Panel
B). This does obscure NPC1 detection, particularly in Fractions 9 and 10 but the shift in density upon loss of NPC2 is clear. However, for this reason, in
quantifying distribution across the gradients of both NPC1 and NPC2, the corresponding lanes from each respective knockout were subtracted as
background. Data are normalized to maximum value. D. Grey-scale matched and magnified inset of NPC2 detected in the L differential fraction from
wild-type and Npc1-mutant mouse liver.
doi:10.1371/journal.pone.0023677.g006
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PL603C1) were generated in-house. Goat anti-rabbit IgG (catalog
number R4880) was obtained from Sigma (St. Louis, MO).
Western blotting
SDS-polyacrylamide gel electrophoresis was conducted using
precast Novex bis-Tris gels and running buffers (Invitrogen,
Carlsbad, CA) as indicated: NPC2 (non-reducing, 4–12%
polyacrylamide, MES buffer), TPP1 (reducing,10% polyacryl-
amide, MOPS buffer), and NPC1 (reducing, 10% polyacrylamide,
MES buffer). Proteins were transferred from the gels to
nitrocellulose membranes using a semi-dry transfer unit (Bio-
Rad Laboratories, Hercules, CA). Membranes were dried and
blocked overnight at 4uC or 1 h at room temperature (RT) in PBS
/ 0.2% Tween 20 containing either 5% dry fat-free milk (TPP1),
1% BSA (NPC1) or 5% BSA (NPC2). Blocked membranes were
incubated overnight at 4uC or 1 h at RT with primary antibody
solutions in PBS / 0.2% Tween 20 containing 5% dry fat-free milk
(TPP1) or 5% BSA (NPC1, NPC2). Membranes were then washed
3 times with PBS / 0.2% Tween 20 for 10 min at RT then
incubated with iodinated goat anti-rabbit IgG for 2 h at RT for
radiographic detection. This antibody was iodinated using
Iodogen (Pierce) and
125I (PerkinElmer, Inc, Waltham, MA).
Following incubation, membranes were washed as before, air
dried, exposed to phosphor storage screens, and scanned using a
Typhoon 9400 scanner (GE Healthcare, Piscataway, NJ). Protein
levels were quantitated using ImageQuant 5.2 (GE Healthcare).
Animals
Npc1 and Npc2 mutants have been described previously [13,27].
The Npc2 mutant allele was introduced into a BALB/c genetic
background by .10 generations of backcrossing to BALB/c mice
while the Npc1 mutation arose from a spontaneous transposon
insertion in BALB/c animals [45]. Experimental animals were
homozygous with respect to wild-type or mutant alleles. For
survival studies, median survival times and 95% confidence
intervals were computed using the survival package in R version
2.13.0 (http://www.R-project.org).
Subcellular fractionation
Four to six week old mice were fasted overnight and then deeply
anesthetized by intraperitoneal injection of sodium pentabarbitol
Figure 7. Distribution of NPC1 and NPC2 in subcellular fractions of brains of wild-type and the NPC-mutant mice. Details are as in
Figure 6 except Panel D is not grey-scale matched.
doi:10.1371/journal.pone.0023677.g007
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Midlothian, VA) and then perfused with saline. Livers and brains
of the animals were removed and resuspended in 2–3 volumes of
ice-cold 0.25 M sucrose in a Potter homogenizer. Tissues were
homogenized by three passages of a motorized rotating pestle
(1500 rpm) from top to bottom of the homogenizer. The resulting
homogenates were subjected to a series of centrifugation steps at
4uC to generate the five fractions (see Results) described by de
Duve et al. [31]. Isopycnic centrifugation on sucrose density
gradients was conducted as described [46] with minor modifica-
tions. The ML fractions were mixed with 1.32 g/cm
3 sucrose
solution to give final density higher than 1.26 g/cm
3. These
samples were applied at the bottom of sucrose density gradients
prepared in 1.05–1.26 g/cm
3 density range. Tubes were centri-
fuged at 40,000 RPM for 150 min in a Sorvall SW50.1 rotor and
then sliced from the top to the bottom into 12 fractions. Densities
Figure 8. Distribution of NPC1 and NPC2 in sucrose density
gradients of ML differential fractions from wild-type mice. NPC1
and NPC2 were quantitated by densitometry from data shown in Figs. 6 and
7.Also shown is thedistributionofthelysosomalmarker,b-galactosidase. A,
liver; B, brain. Data are normalized to fraction of maximum value.
doi:10.1371/journal.pone.0023677.g008
Figure 9. Glycosylation of lysosomal proteins in the liver of
wild-type and NPC-mutant mice. Protein equivalents of the L
differential centrifugation fractions were fractionated on SDS-PAGE gels
and NPC2 and TPP1 were visualized by immunoblotting. Where
indicated (+P), samples were digested with PNGase F prior to SDS-PAGE.
doi:10.1371/journal.pone.0023677.g009
Figure 10. a-Mannosidase activity in livers and brains of wild-
type and NPC-mutant mice. a-Mannosidase activity was normalized
to protein and was measured from 4 mice per group. Error bars
represent standard error of the mean. Using Dunnett’s multiple
comparison test, a-mannosidase activity in brain was significantly
(p,0.001) greater in mice lacking either NPC1 or NPC2 compared to
wild-type. No significant differences were detected in liver.
doi:10.1371/journal.pone.0023677.g010
Effects of NPC Protein Deficiencies on Lysosomes
PLoS ONE | www.plosone.org 10 August 2011 | Volume 6 | Issue 8 | e23677of all the fractions were measured by refractometry and samples
were stored at 280uC prior to use. Enzyme and protein assays
were performed as described previously [28,44,47].
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